The mitochondrial permeability transition
=========================================

The permeability transition (PT) defines an increase of mitochondrial inner membrane permeability to ions and solutes with molecular masses up to about 1500 Da leading to matrix swelling. The occurrence of swelling in isolated mitochondria, its strict dependence on matrix Ca^2+^, stimulation by Pi and fatty acids, and inhibition by Mg^2+^ and adenine nucleotides has been recognized very early (Raaflaub, [@B139],[@B140]; Brenner-Holzach and Raaflaub, [@B29]; Hunter and Ford, [@B84]; Tapley, [@B174]; Lehninger, [@B100]; Lehninger and Remmert, [@B101]; Wojtczak and Lehninger, [@B190]; Zborowski and Wojtczak, [@B195]; Azzi and Azzone, [@B6]; Azzone and Azzi, [@B8]; Chappell and Crofts, [@B34]; Crofts and Chappell, [@B44]); and its detrimental effects on energy conservation have been described before the emergence of chemiosmotic concepts (Mitchell, [@B116], [@B117]). As a result, the PT has initially been considered an *in vitro* artifact of questionable pathophysiological relevance, although a few Authors did recognize its potential importance in pathophysiology (Rasola and Bernardi, [@B142]).

Pfeiffer and Coworkers suggested that the permeabilizing effect of Ca^2+^ had a physiological role in steroidogenesis. These Authors showed that Ca^2+^ induces a "transformation" of adrenal cortex mitochondria allowing diffusion of extramitochondrial pyridine nucleotides through the otherwise impermeable inner membrane, and that NADPH entering in this way supports the 11-β hydroxylation of deoxycorticosterone (Pfeiffer and Tchen, [@B137], [@B138]; Pfeiffer et al., [@B136]). These findings match those of Vinogradov et al., who demonstrated the Ca^2+^-dependent release of matrix pyridine nucleotides in liver mitochondria (Vinogradov et al., [@B181]). The term "permeability transition" was introduced by Haworth and Hunter, who thoroughly characterized its basic features in heart mitochondria. These Authors provided the key insight that the PT was due to reversible opening of a proteinaceous pore in the inner mitochondrial membrane, the permeability transition pore (PTP), whose physiological role remained undefined (Hunter et al., [@B83]; Hunter and Haworth, [@B81],[@B82]; Haworth and Hunter, [@B77]).

Studies on the PT were not too popular at this time, a possible consequence of the general acceptance of the chemiosmotic hypothesis which had just been fully recognized with the award of the Nobel Prize to Peter Mitchell in 1978. As noted earlier (Bernardi, [@B19]) studies of mitochondrial ion transport were indeed carried out in the same laboratories involved in clarifying the mechanisms of energy conservation, and they tended to become tests of the predictions of the chemiosmotic theory. In retrospect it is not too surprising that the existence of a large pore in the inner membrane appeared to contradict the basic tenets of chemiosmosis. As a result, and with very few exceptions (see e.g., Beatrice et al., [@B17]; Coelho and Vercesi, [@B39]; Bernardi and Pietrobon, [@B23]; Lê-Quôc and Lê-Quôc, [@B102], [@B103]; Siliprandi et al., [@B159]; Vercesi, [@B179]; Riley and Pfeiffer, [@B148]; Al Nasser and Crompton, [@B2]; Sokolove and Shinaberry, [@B161]) research in this area did not enjoy much popularity.

The discovery that in mammalian mitochondria the PT can be inhibited by submicromolar concentrations of cyclosporin (Cs) A (Fournier et al., [@B66]; Crompton et al., [@B46]; Broekemeier et al., [@B31]; Davidson and Halestrap, [@B49]) changed the field substantially. CsA inhibits the PTP after binding to matrix cyclophilin (CyP)D, a peptidyl-prolyl *cis-trans* isomerase (PPIase) whose enzymatic activity is blocked by CsA (Fischer et al., [@B61]; Takahashi et al., [@B173]) in the same range of concentrations inhibiting the pore (Connern and Halestrap, [@B40], [@B41]; Nicolli et al., [@B121]; Woodfield et al., [@B191]). A second fundamental finding was the demonstration that mitochondria possess ion channels that can be studied by electrophysiology (Sorgato et al., [@B162]). This seminal study was soon followed by the demonstration that the inner mitochondrial membrane is endowed with a high-conductance (≈1--1.3 nS) channel, the "mitochondrial megachannel" (MMC) (Kinnally et al., [@B93]; Petronilli et al., [@B135]). The MMC is inhibited by CsA (Szabó and Zoratti, [@B170]) and possesses all the key regulatory features of the PTP (Bernardi et al., [@B24]; Szabó et al., [@B167]) leaving little doubt that the PTP and the MMC are two aspects of the same molecular entity (Szabó and Zoratti, [@B171]). Electrophysiology has greatly contributed to our understanding of the MMC--PTP, and to acceptance of the pore theory of the PT (Zoratti et al., [@B197]).

Involvement of the PT in cell death was hypothesized 25 years ago (Crompton and Costi, [@B45]). Early support was obtained in hepatocytes subjected to oxidative stress (Broekemeier et al., [@B30]; Imberti et al., [@B88]), anoxia (Pastorino et al., [@B128]), or treatment with ATP (Zoeteweij et al., [@B196]); and in cardiomyocytes (Duchen et al., [@B55]) and isolated hearts (Griffiths and Halestrap, [@B72]) exposed to ischemia followed by reperfusion. The exponential increase in experimental papers dealing with the PT as an effector mechanism of cell death, however, only followed the demonstration that in the course of apoptosis cytochrome c is released into the cytosol (Liu et al., [@B109]) together with apoptosis-inducing factor (Susin et al., [@B166]) and a set of other proteins involved in the effector phase of apoptosis (Du et al., [@B54]; Ekert et al., [@B56]; Hegde et al., [@B79]; Li et al., [@B107]).

The molecular basis of the PT is still the matter of conjectures (Siemen and Ziemer, [@B157]). The various models and working hypotheses proposed over the years had to cope with the lack of selectivity for the permeating species, the strict requirement for matrix Ca^2+^, which has recently been established also for yeast mitochondria (Yamada et al., [@B192]), the stimulation by oxidants, the existence of a vast number of "inducers" without common structural features, and of a more limited but still substantial number of inhibitors (Gunter and Pfeiffer, [@B74]).

Many suspects, no culprits
==========================

Adenine nucleotide translocator, VDAC, and contact sites
--------------------------------------------------------

Inhibition of mitochondrial swelling by adenine nucleotides has long been appreciated (Raaflaub, [@B140]; Brenner-Holzach and Raaflaub, [@B29]), but the idea that the adenine nucleotide translocator (ANT) is causally involved in the PT probably originates from the finding that Ca^2+^-dependent membrane permeabilization is affected by the ANT inhibitors atractylate and bongkrekate, atractylate being a PT inducer and bongkrekate a PT inhibitor (Hunter and Haworth, [@B81]). While early studies concluded (correctly, as it turns out) that the PT is an inner membrane event, the outer membrane was called into the picture after the work of Brdiczka and coworkers on inner-outer membrane contact sites, i.e., specialized structures where the two membranes form close contacts mediated by protein--protein interactions (Kottke et al., [@B97]). The contact sites were proposed to facilitate channeling of adenine nucleotides to and from mitochondria, and to comprise hexokinase on the cytosolic surface and VDAC within the outer membrane, creatine kinase and nucleoside diphosphate kinase (in tissues that express these proteins), and ANT in the inner membrane (Adams et al., [@B1]; Bucheler et al., [@B32]). The connection with the PTP was made in 1996, when the same laboratory found that hexokinase-enriched fractions formed channels with the conductance expected of the PTP, and conferred permeability properties to liposomes that could be inhibited by N-methylVal-4-cyclosporin (Beutner et al., [@B26]). Unlike the case of MMC, however, currents were inhibited rather than induced by atractylate; the active fractions were not enriched in VDAC or ANT; and the preparation contained a very large number of proteins (Beutner et al., [@B26]) making assignment of the channel activity to a specific species quite problematic. The same hexokinase-enriched fractions were used to study the interactions with proteins of the Bcl-2 family (Marzo et al., [@B112]). The hexokinase/VDAC/ANT model of the PTP was extended to include outer membrane TSPO \[formerly known as peripheral benzodiazepine (Bz) receptor\] and Bcl-2 family members (Zamzami and Kroemer, [@B194]). No further progress was made in the purification of the component(s) mediating channel activity and membrane permeabilization, yet this model became widely accepted as the "structure" of the PTP.

What did we learn from genetic inactivation of putative PTP components
----------------------------------------------------------------------

Conclusive evidence that the ANT is not essential for PTP formation comes from analysis of mitochondria lacking all ANT isoforms, which revealed that a Ca^2+^-dependent PT took place (Kokoszka et al., [@B96]). The PT could be inhibited by CsA and triggered by thiol oxidants, demonstrating that the ANT is neither the obligatory binding partner of CyPD nor the site of action of oxidants (Kokoszka et al., [@B96]) as suggested earlier (Costantini et al., [@B43]). In addition, hepatocytes prepared from control and ANT-deficient livers showed identical responses to activation of receptor-mediated apoptotic pathways initiated by TNFα and Fas (Kokoszka et al., [@B96]). It has been argued that a low, undetectable level of ANT expression could explain the PT observed in ANT-null mitochondria (Halestrap, [@B76]). I believe that this possibility is quite remote because the PTP of mitochondria lacking ANT was insensitive to opening by atractylate and to closure by ADP (Kokoszka et al., [@B96]). As noted elsewhere (Bernardi et al., [@B20]) it is very difficult to envisage how any ANT molecules present in mutant mitochondria would promote a CsA-sensitive PT and yet not respond to atractylate and ADP.

A detailed comparison of the PT in mitochondria from wild-type and *Vdac1^−/−^* mice demonstrated that VDAC1 is fully dispensable for PTP opening and regulation (Krauskopf et al., [@B99]). Furthermore, the PT of mitochondria prepared from *Vdac3^−/−^* and *Vdac1^−/−^Vdac3^−/−^* mice, or from fibroblasts lacking all three VDAC isoforms, was identical to that of strain-matched wild-type mitochondria (Baines et al., [@B10]). Taken together, these results clearly indicate that VDACs are not components of the PTP although, as discussed later in the review, the outer membrane appears to participate in PTP regulation (Sinha Roy et al., [@B160]; Šileikyte et al., [@B158]).

TSPO is an 18 kDa highly hydrophobic protein, involved in cholesterol and protophorphyrin transport, which is located in the outer mitochondrial membrane (Batarseh and Papadopoulos, [@B16]). It was initially identified as a binding site for Bz in tissues that lack GABA receptors (Anholt et al., [@B4], [@B5]). TSPO binds with nM affinity a variety of ligands, notably the Bz Ro5-4864 and the isoquinoline carboxamide PK11195 (Verma et al., [@B180]) as well as protoporphyrin IX, a potent inducer of the PTP (Pastorino et al., [@B127]). Treatment with TSPO ligands does affect the channel activity of the MMC--PTP in the proper concentration range (Kinnally et al., [@B94]) but TSPO is not the only mitochondrial protein binding these compounds, which have been shown to interact with, and inhibit, the F~O~F~1~ ATP synthase (Cleary et al., [@B37]). The latter finding acquires a particular meaning in the light of our recent demonstration that F~O~F~1~ ATP synthase dimers form channels indistinguishable from the PTP that can be activated by Bz-423 (Giorgio et al., [@B71]). Perhaps not surprisingly then, the PTP of mitochondria from mice where expression of TSPO had been conditionally inactivated could still be sensitized to Ca^2+^ by TSPO ligands, and had general features indistinguishable from those of mitochondria isolated from mice with wild-type genotype (Šileikytė, Forte et al., unpublished observations).

In summary, what we learned from gene inactivation studies is that none of the channel-forming proteins suggested to take part in PTP formation is necessary for its occurrence.

Alternative models for PTP formation
------------------------------------

The Halestrap laboratory has proposed a new model for the PTP that envisions the formation of a pore by the Pi carrier (Leung et al., [@B105]). PTP formation would be favored by Ca^2+^ and CyPD binding, and the open probability would be increased by formation of a heterodimer with the ANT (Leung and Halestrap, [@B104]). This model still needs to be tested by reconstitution and by genetic means, but it should be noted that patch-clamp experiments with the functionally active mitochondrial Pi carrier revealed an anion-selective channel function with a mean conductance as low as 40 pS (the typical conductance of the PTP is 1.0−1.3 nS, and the channel is not ion-selective). Furthermore, the current was decreased to 25 pS by both Ca^2+^ (which activates the PTP) and Mg^2+^ (which inhibits it). Finally, and at striking variance with the pore, channel activity was inhibited by Pi and unaffected by ADP (Herick et al., [@B80]). These features make the Pi carrier a very unlikely candidate as a PTP component.

A radically different model of the PTP has been proposed in which the pore does not form from a specific protein but rather from aggregation of misfolded integral membrane proteins damaged by oxidant and other stresses (Kowaltowski et al., [@B98]; He and Lemasters, [@B78]). In the hypothesis of He and Lemasters conductance through misfolded protein clusters would be normally blocked by chaperone-like proteins (including CyPD) and modulated by Ca^2+^ and CsA. Opening of "unregulated" pores would occur when protein clusters exceed available chaperones (He and Lemasters, [@B78]). This model fails to account for the absolute Ca^2+^ requirement of PTP, and its regulation by voltage (Bernardi, [@B18]), matrix pH (Nicolli et al., [@B122]), and adenine nucleotides, all effects that are not easy to reconcile with a permeability pathway created by a heterogeneous set of denatured proteins.

It should be mentioned that Ca^2+^-dependent, CsA-insensitive PT-like channel activities have been described that are formed or activated by 3-hydroxybutyrate/polyphosphate (Pavlov et al., [@B130]) and by fatty acids (Mironova et al., [@B115]; Sultan and Sokolove, [@B165]). The latter observation links to early work demonstrating that fatty acids are potent inducers of mitochondrial swelling (Lehninger and Remmert, [@B101]; Wojtczak and Lehninger, [@B190]), which was later recognized to be due to PTP opening (Scorrano et al., [@B155]; Bernardi et al., [@B21]).

Cyclophilin D and F~o~F~1~ ATP synthase
=======================================

CyPs are ubiquitous, conserved proteins possessing PPIase activity (Fischer et al., [@B61]; Takahashi et al., [@B173]) sharing a common domain of about 109 amino acids, the CyP-like domain (Wang and Heitman, [@B187]). In man 16 unique CyPs have been found, the prototype being cytosolic CyPA (Wang and Heitman, [@B187]). After binding CsA the PPIase activity is inhibited (Borel et al., [@B28]) and the CsA/CyPA complex binds to and inhibits the cytosolic phosphatase calcineurin (Liu et al., [@B108]), causing immunosuppression (Clipstone and Crabtree, [@B38]; Walsh et al., [@B183]).

CyPD is the mitochondrial CyP isoform in mammals (Connern and Halestrap, [@B40]; Nicolli et al., [@B121]; Woodfield et al., [@B191]), see Giorgio et al. ([@B70]) for a review. Much on its role in PTP regulation has been learned by genetic ablation of the *Ppif* gene (which encodes for CyPD). CyPD is the mitochondrial receptor for CsA and modulates the PTP but is not a structural pore component (Baines et al., [@B9]; Basso et al., [@B13]; Nakagawa et al., [@B119]; Schinzel et al., [@B150]). As discussed elsewhere (Bernardi et al., [@B20]), the effect of CsA on the PTP is best described as "desensitization" in the sense that the PTP becomes more resistant to opening by Ca^2+^ and Pi. It should be stressed that pore opening readily takes place for Ca^2+^-Pi loads that are about twice those required in wild-type mitochondria. This indicates that *Ppif^−/−^ (CyPD-null) mitochondria are not null for the PTP.* This consideration is important for the interpretation of results obtained with CsA because (similarly to the absence of CyPD) CsA can desensitize but not block the PTP; thus, lack of sensitivity to CsA does not necessarily mean that the PTP is not involved in the event being studied. Furthermore, expression of CyPD is modulated, e.g., by muscle denervation (Csukly et al., [@B47]), and only CyPD-expressing mitochondria respond to CsA (Li et al., [@B106]). No endogenous ligands of CyPD mimicking the effects of CsA are known, but other PTP (de)sensitizers might act by favoring CyPD association or dissociation, as documented for acidic pH and increasing ionic strength (Nicolli et al., [@B121]). Furthermore, CyPD phosphorylation (Rasola et al., [@B144]), acetylation (Shulga and Pastorino, [@B156]), and nitrosylation (Kohr et al., [@B95]; Nguyen et al., [@B120]) affect the propensity of the PTP to open (Rasola and Bernardi, [@B143]). Not surprisingly CyPD may interact with many proteins including Hsp90 and its related molecule TRAP-1 (Kang et al., [@B91]); Bcl-2 (Eliseev et al., [@B57]); ERK-2/GSK-3 (Rasola et al., [@B144]); possibly p53 (Vaseva et al., [@B178]), but see (Karch and Molkentin, [@B92]); and the F~O~F~1~ ATP synthase (Giorgio et al., [@B68]). The latter interaction turned out to be the key for identification of the PTP.

The F~O~F~1~ ATP synthase (or complex V) is the rotary enzyme that synthesizes the vast majority of ATP in respiring cells (Rees et al., [@B145]). It is formed by the catalytic F~1~, the membrane-bound proton-translocating F~O~, and the lateral stalk linking F~1~ and F~O~ (Strauss et al., [@B164]; Thomas et al., [@B175]; Rees et al., [@B145]; Baker et al., [@B11]; Davies et al., [@B50]) (Figure [1](#F1){ref-type="fig"}). The lateral stalk acts as a stator preventing the α~3~β~3~ subcomplex of F~1~ from rotating with subunits γ, δ, and ε and the ring of F~O~-subunits c (Rees et al., [@B145]). The F~O~F~1~ ATP synthase complex associates to form dimers, which are considered to be the "building blocks" of long rows of oligomers that promote cristae formation and may optimize the enzyme\'s catalytic performance (Campanella et al., [@B33]; Strauss et al., [@B164]; Thomas et al., [@B175]; Rees et al., [@B145]; Baker et al., [@B11]; Davies et al., [@B50]). The angle formed by the dimers seems to display a large variability, and dimers are believed to represent the physiological unit of complex V in the inner membrane (Thomas et al., [@B175]).

![**Schematic representation of F~O~F~1~ ATP synthase dimers.** F~1~ (dark blue), F~O~ (green and light blue), and stalk subunits (red) are illustrated based on recent structural studies (Strauss et al., [@B164]; Baker et al., [@B11]; Davies et al., [@B50]).](fphys-04-00095-g0001){#F1}

We found that CyPD binds the lateral stalk of complex V in an apparent ratio of 1:1:1:1 with the OSCP, b and d subunits (Giorgio et al., [@B68]). CyPD binding requires Pi and results in partial inhibition of ATP synthase activity, while CsA displaces CyPD resulting in enzyme reactivation (Giorgio et al., [@B68]). The stimulatory effect of CsA on enzyme catalysis is lost in *Ppif*^−/−^ mitochondria, proving that it is mediated by CyPD, while assembly of the ATP synthase is not affected by CyPD ablation (Giorgio et al., [@B68]). In spite of the striking analogies with PTP regulation (Pi dependence, CsA sensitivity) whether the interactions of CyPD with complex V are relevant for the PT remained unknown until very recently.

Dimers of F~o~F~1~ ATP synthase form channels indistinguishable from the MMC--PTP
=================================================================================

We have defined the binding site of CyPD on ATP synthase to the OSCP subunit, and shown that the interaction is electrostatic in nature. Modeling of surface potentials and isopotential curves suggested that CyPD interacts with OSCP in a region overlapping with helices 3 and 4, and this turned out to be a key insight (Giorgio et al., [@B71]). Indeed, this is also the binding site of Bz-423, a well-characterized inhibitor of the F~O~F~1~ ATP synthase (Johnson et al., [@B89]; Stelzer et al., [@B163]). If the CyPD interactions are important for the PT, it was logical to expect that Bz-423 should act as a PTP inducer, and this was the case. Bz-423 sensitized the PTP to Ca^2+^, and the inducing effect was blunted by Pi at concentrations that increase CyPD binding to OSCP (Giorgio et al., [@B71]). Consistent with an involvement of complex V in PTP formation, decreased levels of OSCP did affect the Ca^2+^ dependence of the pore. Indeed, mitochondria took up Ca^2+^ normally when ATP was used as the energy source, but the threshold Ca^2+^ load required for PTP opening was halved, which is the first molecular evidence that OSCP affects the probability of pore opening. Consistent with a key role of the ATP synthase, the Ca^2+^ affinity of the PTP was also affected by enzyme catalysis in the sense that ATP-hydrolyzing mitochondria required twice the Ca^2+^ load of ATP-synthesizing organelles, an effect as large as that of CsA (Giorgio et al., [@B71]).

Direct evidence that the PTP forms from the F~O~F~1~ ATP synthase was obtained by incorporating dimers purified by blue native electrophoresis into azolectin bilayers, and by measuring the passage of currents after application of a voltage difference. Addition of Bz-423 in the presence of Ca^2+^ triggered opening of high-conductance channels that were blocked by Mg^2+^/ADP and by the ATP synthase inhibitor AMP-PNP (γ-imino ATP, a non hydrolyzable ATP analog). Monomers of ATP synthase were devoid of channel activity in spite of the same overall subunit composition as the dimers (Tomasetig et al., [@B176]; Giorgio et al., [@B71]). The characteristics of the reconstituted pore closely matched those of MMC--PTP (Petronilli et al., [@B135]; Szabó and Zoratti, [@B170]; Szabó et al., [@B167]). Maximal chord conductance was between 1.0 and 1.3 nS in symmetrical KCl 150 mM, and various subconductance states were observed. Like the MMC of *Ppif*^−/−^ mitochondria (De Marchi et al., [@B52]), and in keeping with the lack of CyPD in the preparations, the channel was insensitive to CsA. Ca^2+^ and Pi, which sensitize the PTP even in the absence of CyPD, sufficed to induce PTP currents when dimers were prepared in the presence of 10 mM Pi. Channel openings could not be elicited by atractyloside and, once elicited by Bz-423, were still observed in the presence of bongkrekic acid. These findings are consistent with the absence of ANT in the preparations, which also totally lacked VDAC (Giorgio et al., [@B71]).

Bz-423 was characterized as an apoptosis-inducing agent acting through mitochondria (Blatt et al., [@B27]) and OSCP was identified as its target through the unbiased screening of a human phage display library (Johnson et al., [@B89]). The selectivity of action of Bz-423 on OSCP, its ability to trigger channel activity of ATP synthase dimers, and the lack of activity of monomer preparations strongly argues against the possibility that the currents observed by Giorgio et al. ([@B71]) are due to unidentified contaminating proteins. The PTP-inducing effect of Bz-423 and CyPD (which both act through OSCP on top of the lateral stalk in the matrix) must be indirect, as it affects the permeability properties of the inner membrane. We assume that the PTP forms at the membrane interface between two adjacent F~O~ sectors, which could also accommodate the effects of fatty acids (Lehninger and Remmert, [@B101]; Wojtczak and Lehninger, [@B190]; Bernardi et al., [@B21]). Matrix Ca^2+^ has an essential permissive role in PTP formation, and we have suggested that accessibility of Ca^2+^ to the metal binding sites of the catalytic F~1~ sector is influenced by OSCP. This subunit could indeed affect the affinity of the metal binding sites of ATP synthase and thus determine the ease with which matrix Ca^2+^ can replace Mg^2+^ causing PTP opening. Our working hypothesis is that OSCP as such is a "negative" modulator, whose effect can be counteracted by binding of the "positive" effector CyPD (which indeed increases the apparent Ca^2+^ affinity of the PTP). Removal of OSCP, or CyPD binding to OSCP, would induce similar conformational effects leading to increased probability of PTP opening, a working hypothesis that awaits experimental verification.

A cartoon with the hypothetical events leading to PTP formation from complex V dimers is presented in Figure [2](#F2){ref-type="fig"}. In the "coupled" condition the dimers bind Mg^2+^-ADP/ATP, and the concentration of free Ca^2+^ (and Pi, not shown in the Figure) is not high enough for the PT to occur (panel **A**). Binding of CyPD, which is favored by Pi (Giorgio et al., [@B68]), would cause a conformational change affecting accessibility of the metal binding sites. This in turn would decrease the matrix Ca^2+^ load necessary to trigger the PT (panels **B,D**). The transition would essentially depend on replacement of Mg^2+^ with Ca^2+^, which in the absence of CyPD binding would require higher matrix Ca^2+^ loads (panel **C**). Accessibility of the metal binding site (and probability of occurrence of the PT at a given Ca^2+^ load) would be increased by thiol oxidation and counteracted by thiol reduction. Ion and solute permeation would then occur at the interface between the c rings (panels **C,D**). The PT can be fully reverted by Ca^2+^ chelation with EGTA (Petronilli et al., [@B132]), which would restore Mg^2+^ binding and allow the dimer to recover the coupled structure.

![**Hypothetical transition of F~O~F~1~ ATP synthase dimers to form the PTP.** ATP synthase dimers **(A)** can undergo PTP formation when Ca^2+^ rather than Mg^2+^ is bound, possibly at the catalytic sites, in a reversible process favored by thiol oxidation **(C)**. Binding of CyPD, which is favored by Pi **(B)** would increase the accessibility of the metal binding sites, allowing PTP formation at lower Ca^2+^ concentrations (as depicted here by a smaller face type) **(D)**. Adenine nucleotides counteract PTP formation in synergy with Mg^2+^. Red arrows denote the hypothetical pathway for solute diffusion between two F~O~ subunits.](fphys-04-00095-g0002){#F2}

A mystery solved, more mysteries to solve
=========================================

Role of outer membrane
----------------------

It can no longer be questioned that the PT is an inner membrane event since (1) complex V dimers suffice to induce MMC activity and (2) Ca^2+^-dependent PT occurs in mitoplasts, i.e., mitochondria stripped of the outer membrane (Šileikyte et al., [@B158]). These findings should not be taken to imply that the outer membrane does not play a role in PTP modulation, which is in fact supported by a large number of studies. An early indication was provided by Lê-Quôc and Lê-Quôc, who showed that induction of the PTP by substituted maleimides requires the outer membrane (Lê-Quôc and Lê-Quôc, [@B103]). We have fully confirmed this "sensitizing" role of the outer membrane by an independent approach, i.e., irradiation of mitochondria with visible light after treatment with hematoporphyrin, a strategy that allows production of singlet oxygen leading to PTP inactivation or reactivation depending on the light dose (Ricchelli et al., [@B147]). Low light doses inactivate the PTP through degradation of hystidyl residues that prevent cysteine oxidation on the matrix side (Salet et al., [@B149]), while higher light doses activate the PTP through cysteine oxidation at the outer membrane (Moreno et al., [@B118]; Petronilli et al., [@B134]). Mitoplasts are completely resistant to PTP induction by high light doses (Šileikyte et al., [@B158]) proving that the outer membrane can favor PTP opening through a still unidentified mechanism (Ricchelli et al., [@B147]).

Bcl-2 family proteins, which are generally believed to locate to the outer membrane, affect the PTP (Forte and Bernardi, [@B65]). According to several studies Bcl-2 increases resistance to the PT (Susin et al., [@B166]; Decaudin et al., [@B51a]) while Bax and/or Bad activated by tBid favor PTP opening (Pastorino et al., [@B124], [@B129]; Scorrano et al., [@B153]; Sinha Roy et al., [@B160]). Although CsA did not prevent cytochrome c release in one study where tBid was used, it is not known whether the cells expressed CyPD and were therefore sensitive to CsA inhibition (Garcia-Perez et al., [@B67]), an issue that may explain discrepancies with earlier studies (Scorrano et al., [@B153]; Tafani et al., [@B172]). Occurrence of a PT is instead opposed by outer membrane binding of hexokinase II (Pastorino et al., [@B126], [@B125]; Chiara et al., [@B36]), which counteracts the inducing effects of Bax (Pastorino et al., [@B126]). It must be mentioned that Bcl-2 family proteins also interact with other targets. Indeed, tBid initiates a CsA-sensitive process of cristae remodeling that increases cytochrome c availability in the intermembrane space, which is consistent with a PT-dependent facilitation of cytochrome c release even when the outer membrane is intact (Scorrano et al., [@B153], [@B154]); and Bax inhibits the mitochondrial inner membrane potassium channel Kv1.3 (Szabó et al., [@B168]), a proapoptotic effect that critically depends on Bax residue K128 and is abrogated by a K128E mutation, while an E158K mutation in antiapoptotic Bcl-xL (position 158 of Bcl-xL corresponds to position 128 of Bax) turns Bcl-xL into a proapoptotic protein (Szabó et al., [@B169]).

The detailed mechanisms through which the outer membrane affects formation of the PTP remain to be addressed. I would like to stress that the vast majority of complex V is located in long rows of oligomers deep inside mitochondrial cristae (Strauss et al., [@B164]; Davies et al., [@B51], [@B50]) where direct physical interaction with the outer membrane is obviously not possible. Thus, either the PTP forms in the small population of dimers facing the intermembrane space, where direct contact with the outer membrane can occur; or the effect is exerted by controlling the diffusion of PTP-regulating metabolites and ions including Ca^2+^ itself (Madesh and Hajnoczky, [@B110]; Rapizzi et al., [@B141]) in a process that would be greatly favored by cristae remodeling (Scorrano et al., [@B153]).

The PTP as a calcium release channel
------------------------------------

We have recently reviewed the hypothesis (Bernardi and Petronilli, [@B22]; Ichas et al., [@B87]) that the PTP may open transiently (Hüser et al., [@B86]; Hüser and Blatter, [@B85]; Petronilli et al., [@B131], [@B133]) to operate as a mitochondrial Ca^2+^ release channel under physiological conditions (Bernardi and von Stockum, [@B25]). The basis for this hypothesis goes back to 1992, when Altschuld et al. reported that CsA significantly increases net Ca^2+^ uptake and decreases Ca^2+^ efflux in isolated cardiomyocytes, as measured by radiolabeled ^45^Ca^2+^, through a demonstrably mitochondrial effect that has no impact on cell morphology or viability (Altschuld et al., [@B3]). Three recent publications based on *Ppif*^−/−^ cells and mice support this hypothesis (Elrod et al., [@B59]; Barsukova et al., [@B12]; Parone et al., [@B123]).

An age-related phenotype was discovered in the hearts of *Ppif*^−/−^ mice, which dysplayed decreased contractile reserve and increased shortening and relaxation times, with longer decay of cytosolic Ca^2+^ transients (Elrod et al., [@B59]). Direct measurement of total mitochondrial Ca^2+^ content of *Ppif*^−/−^ hearts showed a 2.6-fold increase, which was matched by larger Ca^2+^ transients in mitochondria of myocytes treated with CsA. Under continuous pacing PTP desensitization with CsA decreased the rise time in Ca^2+^ accumulation and prolonged the recovery time after pacing, findings that are entirely consistent with the PTP acting as a Ca^2+^ release channel to prevent Ca^2+^ overload (Elrod et al., [@B59]). Consistent with this idea, cytosolic \[Ca^2+^\] increases induced by either ATP or depolarizing concentrations of KCl gave comparable transient increases of mitochondrial \[Ca^2+^\] in adult cortical neurons from wild type and *Ppif*^−/−^ mice; while application of the two stimuli together resulted in much higher levels of mitochondrial \[Ca^2+^\] in the *Ppif*^−/−^ neurons, suggesting that the threshold for PTP activation had been reached in the wild type but not in the CyPD-null mitochondria *in situ*. These data indicate that the regulatory role of CyPD (and thus PTP opening) in Ca^2+^ homeostasis may be essential only for relatively large mitochondrial Ca^2+^ loads (Barsukova et al., [@B12]). Mice expressing amyotrophic lateral sclerosis-linked mutants of superoxide dismutase (SOD) 1 develop a motor neuron disease with many pathological hallmarks seen in patients (Gurney et al., [@B75]). Spinal cord mitochondria from these mice display decreased Ca^2+^ retention capacity long before onset of motor weakness and neuronal death (Damiano et al., [@B48]), and this was corrected by genetic elimination of the *Ppif*^−/−^ gene (Parone et al., [@B123]). Improved mitochondrial Ca^2+^ buffering was matched by improved mitochondrial ATP synthesis and reduced swelling, attenuation of glial activation, reduction of misfolded SOD1 aggregates in the spinal cord, and significant suppression of motor neuron death throughout disease, although survival was unfortunately not improved (Parone et al., [@B123]).

Transient PTP openings appear also to be at the basis of "superoxide flashes" observed with mitochondrially targeted, circularly permuted yellow fluorescent protein (mt-cpYFP) in a variety of cell types (Wang et al., [@B188], [@B186]; Fang et al., [@B60]). There is an ongoing debate on whether the flashes are in fact partially or totally due to changes of matrix pH (Schwarzlander et al., [@B151], [@B152]), although it is fair to say that the measured matrix alkalinization appears to be way too small to account for the fluorescence changes of mt-cpYFP (Wei-Lapierre et al., [@B189]).

The recent finding that Drosophila mitochondria possess a PTP-related but CsA-insensitive Ca^2+^ release channel selective for Ca^2+^ and H^+^ (von Stockum et al., [@B182]) provides a nice model system, and perhaps the missing link between the PTP of yeast and mammals (Azzolin et al., [@B7]). I am confident that it will be now possible to address the potential role of the PTP as a Ca^2+^ release channel through inhibition of the "pore function" of ATP synthase dimers through appropriate drugs and through genetic manipulation.

Complex I
---------

The PTP has the remarkable feature of being modulated by electron flow through complex I (Fontaine et al., [@B63]), which may in part be linked to the fact that NADH oxidation favors PTP opening (Costantini et al., [@B42]). A specific role of complex I, however, is suggested by the striking discovery that in mammalian mitochondria rotenone can be an effective inhibitor of the pore (Chauvin et al., [@B35]; Li et al., [@B106]). Inhibition of the PT by rotenone is maximal in mitochondria from tissues that express low levels of CyPD, where CsA has little inhibitory effect; while inhibition by CsA is maximal in mitochondria from tissues with high levels of expression of CyPD, where rotenone does not affect the PTP. Finally, tissues with mitochondria expressing intermediate levels of CyPD are sensitive to both rotenone and CsA, with additive effects of the two inhibitors (Li et al., [@B106]). Intriguingly, the inhibitory effect of rotenone is potentiated by Pi, which is reminiscent of the Pi requirement for inhibition by CsA (Basso et al., [@B14]). The concentrations of rotenone required for PT inhibition matched quite precisely those required to inhibit respiration, and a similar PT-inhibiting effect was seen with metformin, which partially inhibits complex I as well (El Mir et al., [@B58]; Guigas et al., [@B73]). Since rotenone and metformin do not share common structural features, it appears likely that modulation of the PTP by inhibition of complex I is indirect, and possibly mediated by inhibition of complex I-derived reactive oxygen species (Batandier et al., [@B15]). An indirect effect is also suggested by the observations (1) that a Ca^2+^-dependent (albeit CsA-insensitive) PT can occur in mitochondria from yeast strains that do not possess an energy-conserving complex I (Jung et al., [@B90]; Yamada et al., [@B192]; Uribe-Carvajal et al., [@B177]); (2) that complex I purified by blue native electrophoresis did not form Ca^2+^-activated channels in lipid bilayers under conditions that instead promote MMC opening after incorporation of complex V (Giorgio et al., [@B71]); and (3) that complex I does not colocalize with ATP synthase oligomers (Davies et al., [@B51]).

Quinones
--------

The regulatory effects of quinones on the PTP has been discovered in our laboratory in 1998 (Fontaine et al., [@B63],[@B64]) and thoroughly characterized by Fontaine and Coworkers (Walter et al., [@B185], [@B184]; Devun et al., [@B53]). Ub0 (i.e., ubiquinone without a side chain) is the most potent inhibitor of the PTP; the dose-dependence displays a bell-shaped curve, however, a feature that is also typical of other inhibitory quinones like decylubiquinone (Fontaine et al., [@B63],[@B64]; Fontaine and Bernardi, [@B62]; Walter et al., [@B185]). PTP-inducing quinones include idebenone (Walter et al., [@B185]) while idebenol (the reduced form) is no longer effective, suggesting that the effect on the PTP is related to oxidation-reduction events (Giorgio et al., [@B69]). The structure--function relationship of quinones for PTP inhibition/activation has not been solved, and further complexity arises from the fact that the same quinone can have opposite effects depending on the cell type (Devun et al., [@B53]). It appears possible that, like substituted maleimides, Ub0 affects PTP formation in part at least through its ability to form adducts with SH groups, which is not shared by short-chain quinones. ROS-forming ability of the latter does not always correlate with their PTP-inducing features (Devun et al., [@B53]) and the general mechanism of action of quinones on the PT remains to be solved.

Conclusions and perspectives
============================

The findings that (1) dimers of the ATP synthase treated with Ca^2+^ generate currents indistinguishable from the MMC--PTP; (2) channel openings are favored by Bz-423 and thiol oxidants; (3) channel openings are inhibited by adenine nucleotides and Mg^2+^; and (4) monomers lack any channel activity, all represent strong indications that the PTP forms from a specific, Ca^2+^-dependent conformation of the dimers. The F~O~F~1~ ATP synthase readily accommodates key pathophysiological effectors of the PT since Ca^2+^, Mg^2+^, adenine nucleotides, and Pi bind the catalytic core at F~1~; and the membrane potential and matrix pH, which are key PTP modulators (Bernardi et al., [@B20]), are also key regulators of the ATP synthase. On the other hand, several regulators of the PTP (specifically, rotenone and quinones) are not easily accounted for by the dimer hypothesis, and their mechanism of action will need further studies. However, I believe that our findings provide a novel and stimulating working hypothesis that should help address outstanding issues including species-specific features of the PTP of rats (Ricchelli et al., [@B146]; Zulian et al., [@B198]), yeast (Jung et al., [@B90]; Manon et al., [@B111]; Yamada et al., [@B192]; Uribe-Carvajal et al., [@B177]), and *Drosophila melanogaster* (von Stockum et al., [@B182]); and the mystery of *Artemia franciscana*, an anoxia and salt-tolerant brine shrimp whose mitochondria are refractory to PTP opening (Menze et al., [@B114], [@B113]). Together our results suggest a dual function for complex V, ATP synthesis and PTP formation. The key enzyme of life appears therefore to be also the molecular switch that signals the presence of fully depolarized, dysfunctional mitochondria to promote cell death (Rasola and Bernardi, [@B143]) and/or mitophagy (Youle and Narendra, [@B193]).
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